Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.
BI Nutraceuticals CEO will discuss the legislative landscape surrounding GMOs and how suppliers and manufacturers can be prepared if GMO labeling legislation eventually passes.
February 22, 2015
1 Min Read
As part of a Clean Label education track being presented at Engredea 2015, George Pontiakos, president and CEO of BI Nutraceuticals, will discuss the legislative landscape surrounding the use of GMOs and the steps suppliers and manufacturers need to take in order to be prepared if GMO-labeling legislation eventually passes. The session, “Understanding the cost and complexity of GMO labeling,” will take place Thursday, March 5 from 1:45 to 2:45 p.m. in the Marriott Orange County Ballroom 3/4, located adjacent to the Anaheim Convention Center.
During this session, Pontiakos will cover:
Defining “What is GMO”
Sourcing non—GMO ingredients
How GMO legislation will impact the supply chain - from both a cost and complexity perspective
Testing parameters for non-GMO ingredients
Why they industry must do a stronger job of interdicting GMO legislation before it gets traction
If and when we will see government mandated GMO labeling
Should a raw material supplier be required to be non-GMO verified - or are they already doing that? What is the value of the non-GMO verified seal to a supplier?
As president and CEO, Pontiakos oversees all aspects of operations for BI Nutraceuticals’ west and east coast offices, and the Zuellig Group Nutrition and Ingredients, China. Pontiakos has held senior leadership positions at several leading consulting, medical services and technology companies including Monovasia, which he founded, Oluma, Lucent, Agere, Ortel, NetVantage and Timeplex. He has wide-ranging experience in scaling geographically dispersed, globally competitive companies to maximize their ability to successfully compete in the marketplace.
You May Also Like
